Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:DAL NASDAQ:PPH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDALDelta Air Lines$73.71-0.6%$67.56$45.28▼$76.39$48.19B1.2510.32 million shs2.75 million shsPPHVanEck Pharmaceutical ETF$103.12+0.5%$102.50$81.74▼$112.58$978.61M0.46342,437 shs64,452 shsThe 7 Hottest IPOs On Wall Street’s 2026 WatchlistMarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDALDelta Air Lines+9.33%+4.24%+4.15%+9.90%+47.86%PPHVanEck Pharmaceutical ETF+0.14%+0.47%-0.94%-7.53%+17.78%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDALDelta Air Lines$73.71-0.6%$67.56$45.28▼$76.39$48.19B1.2510.32 million shs2.75 million shsPPHVanEck Pharmaceutical ETF$103.12+0.5%$102.50$81.74▼$112.58$978.61M0.46342,437 shs64,452 shsThe 7 Hottest IPOs On Wall Street’s 2026 WatchlistMarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDALDelta Air Lines+9.33%+4.24%+4.15%+9.90%+47.86%PPHVanEck Pharmaceutical ETF+0.14%+0.47%-0.94%-7.53%+17.78%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDALDelta Air Lines 2.96Moderate Buy$79.768.21% UpsidePPHVanEck Pharmaceutical ETF 2.61Moderate Buy$103.12N/ACurrent Analyst Ratings BreakdownLatest WTB, MLC, DAL, and PPH Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/11/2026DALDelta Air Lines Sanford C. BernsteinSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$81.00 ➝ $88.005/11/2026DALDelta Air Lines Sanford C. BernsteinSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$81.00 ➝ $88.005/7/2026DALDelta Air Lines UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$86.00 ➝ $95.004/21/2026DALDelta Air Lines BNP Paribas ExaneSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOutperform$85.00 ➝ $81.004/17/2026DALDelta Air Lines EvercoreSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform$85.004/15/2026DALDelta Air Lines Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong Sell ➝ Hold4/13/2026DALDelta Air Lines Jefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$78.00 ➝ $81.004/9/2026DALDelta Air Lines UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$84.00 ➝ $86.004/9/2026DALDelta Air Lines SusquehannaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetPositive$81.00 ➝ $78.004/9/2026DALDelta Air Lines TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$76.00 ➝ $84.00(Data available from 5/21/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDALDelta Air Lines$65.18B0.74$10.41 per share7.08$31.01 per share2.38PPHVanEck Pharmaceutical ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDALDelta Air Lines$5.01B$6.8610.699.780.986.87%20.28%4.85%7/9/2026 (Estimated)PPHVanEck Pharmaceutical ETFN/AN/A20.21N/AN/AN/AN/AN/AN/ALatest WTB, MLC, DAL, and PPH EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/8/2026Q1 2026DALDelta Air Lines$0.61$0.64+$0.03-$0.44$14.05 billion$14.20 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthDALDelta Air Lines$0.751.02%+11.20%10.93%1 YearsPPHVanEck Pharmaceutical ETF$2.152.08%N/AN/AN/ALatest WTB, MLC, DAL, and PPH DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/15/2026DALDelta Air Linesquarterly$0.18751.05%5/14/20265/14/20266/4/20263/31/2026PPHVanEck Pharmaceutical ETFQuarterly$0.84413.23%4/1/20264/1/20264/7/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDALDelta Air Lines0.540.420.36PPHVanEck Pharmaceutical ETFN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDALDelta Air Lines69.93%PPHVanEck Pharmaceutical ETFN/AInsider OwnershipCompanyInsider OwnershipDALDelta Air Lines0.80%PPHVanEck Pharmaceutical ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDALDelta Air Lines100,000656.99 million651.74 millionOptionablePPHVanEck Pharmaceutical ETF147,0009.49 millionN/AOptionableWTB, MLC, DAL, and PPH HeadlinesRecent News About These CompaniesDitch or Double Down on This Pharma ETF as Trump Adjusts Drug Prices?May 19 at 4:19 PM | 247wallst.comShould You Invest in the Invesco Pharmaceuticals ETF (PJP)?April 29, 2026 | zacks.comShould You Invest in the VanEck Pharmaceutical ETF (PPH)?April 2, 2026 | zacks.comVanEck Vectors Pharmaceutical ETF declares quarterly distribution of $0.8441April 1, 2026 | msn.comPPH ETF: Drug Pricing Policy and Eli Lilly Concentration Are the Two Risks to Watch in 2026March 28, 2026 | 247wallst.comBig Pharma's Earnings Week: Strong Performance, Obesity Wars, LOE Management And MoreFebruary 7, 2026 | seekingalpha.comHealthcare ETFs to Watch as Novo Nordisk Tumbles on Poor Sales OutlookFebruary 4, 2026 | zacks.comShould You Invest in the VanEck Pharmaceutical ETF (PPH)?January 28, 2026 | zacks.comVanEck Pharmaceutical ETF $PPH Shares Sold by Adamsbrown Wealth Consultants LLCJanuary 28, 2026 | defenseworld.netDVanEck Pharmaceutical Fund Bets Big on Weight-Loss Drug Market Approaching $150 BillionJanuary 23, 2026 | 247wallst.comNovo Nordisk's Wegovy Pill Shakes Up Rivalry With Eli Lilly, Puts Health Care ETFs In FocusDecember 23, 2025 | benzinga.comWhy PPH Keeps Working When Single Themes BreakDecember 17, 2025 | seekingalpha.comDay by day downgrades VanEck ETF Trust - VanEck Pharmaceutical ETF (PPH)December 16, 2025 | msn.comShould You Invest in the VanEck Pharmaceutical ETF (PPH)?November 27, 2025 | zacks.comOzempic—and 14 other popular prescription drugs—will cost less for Medicare after the U.S. government negotiated lower pricesNovember 25, 2025 | wsj.comCencora Stock: Is Wall Street Bullish or Bearish?November 11, 2025 | msn.comTop Pharmaceutical Companies Shaping the Future of HealthcareNovember 1, 2025 | etftrends.comETop Pharmaceutical Companies Shaping The Future Of HealthcareOctober 28, 2025 | seekingalpha.comIs VanEck Pharmaceutical (PPH) the Best Healthcare ETF to Buy?October 16, 2025 | insidermonkey.comDrug Stocks Just Had Their Best Week in 2 Decades. Should You Invest?October 13, 2025 | fool.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeWTB, MLC, DAL, and PPH Company DescriptionsDelta Air Lines NYSE:DAL$73.71 -0.41 (-0.56%) As of 01:11 PM Eastern This is a fair market value price provided by Massive. Learn more.Delta Air Lines, Inc. provides scheduled air transportation for passengers and cargo in the United States and internationally. The company operates through two segments, Airline and Refinery. Its domestic network centered on core hubs in Atlanta, Minneapolis-St. Paul, Detroit, and Salt Lake City, as well as coastal hub positions in Boston, Los Angeles, New York-LaGuardia, New York-JFK, and Seattle; and international network centered on hubs and market presence in Amsterdam, Bogota, Lima, Mexico City, London-Heathrow, Paris-Charles de Gaulle, Sao Paulo, Seoul-Incheon, and Tokyo. The company sells its tickets through various distribution channels, including delta.com and the Fly Delta app; acts as a reservations specialists; and operates online travel and traditional brick and mortar agencies. It also provides aircraft maintenance and engineering support, repair, and overhaul services; and vacation packages to third-party consumers. The company operates through a fleet of approximately 1,273 aircrafts. Delta Air Lines, Inc. was founded in 1924 and is based in Atlanta, Georgia.VanEck Pharmaceutical ETF NASDAQ:PPH$103.12 +0.52 (+0.51%) As of 12:43 PM EasternThe VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas NVIDIA Price Pullback? Don’t Count on It, Business Is Accelerating Target Shows Strengths, But Analysts Want to See More Freight Boom: The Hormuz Blockade Payday TJX Companies Fires on All Cylinders With 9% Revenue Growth Analog Devices Provides Much-Needed Pullback: How Low Can It Go? USA Rare Earth Posts Strong Q1 2026 as Massive Serra Vera Deal Looms From Zepbound to Foundayo: Lilly's Latest Results Support Oral GLP-1 Outlook Corpay’s Quiet Strength Is Winning Wall Street Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
